Morphine Drugs Market Report 2026

Morphine Drugs Market Overview

• Morphine Drugs market size has reached to $23.09 billion in 2025 • Expected to grow to $30.17 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Increasing Prevalence Of Chronic Pain Driving Growth Of Morphine Drug Market • Market Trend: Advancements in Morphine Sulfate Injection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Morphine Drugs Market?

Morphine drugs refer to a class of medications that contain morphine, a potent opioid analgesic (pain reliever) derived from the opium poppy plant. They are used for relieving moderate to severe pain, commonly after surgery or injury, or in treating conditions like cancer. The main dosage forms of morphine drugs are injectable, oral, and other dosage forms. Injectables are medications or substances that are formulated to be administered into the body via injection, bypassing the digestive system for immediate effect. The various distribution channels include hospital pharmacy, retail pharmacy, and online pharmacy used for various applications such as pain management, palliative care, diarrhea suppressant, anesthesia, cold and cough suppressant, and others and used by various end users such as hospitals and clinics, ambulatory surgical centers, and others.

What Is The Morphine Drugs Market Growth Forecast?

The morphine drugs market size is expected to see strong growth in the next few years. It will grow to $30.17 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising cancer prevalence requiring strong analgesics, growing demand for palliative care services, expansion of hospital infrastructure in emerging markets, continued need for anesthesia and perioperative pain control, balanced opioid use under stricter regulatory frameworks. Major trends in the forecast period include sustained demand for opioid analgesics in severe pain management, continued use of morphine in palliative and end-of-life care, preference for injectable morphine in hospital settings, availability of multiple dosage forms for clinical flexibility, growing emphasis on controlled and regulated opioid prescribing.

Global Morphine Drugs Market Segmentation

1) By Dosage form: Injectable, Oral, Other Dosage Forms 2) By Distribution channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy 3) By Applications: Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Other Applications 4) By End Users: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Injectable: Morphine Sulfate Injection, Morphine Hydrochloride Injection, Morphine Extended Release Injection 2) By Oral: Oral Tablets (Immediate-Release, Extended-Release), Oral Solution Or syrup, Oral Capsules (Extended-Release Capsules) 3) By Other Dosage Forms: Rectal Suppositories, Sublingual Tablets Or Films

What Is The Driver Of The Morphine Drugs Market?

The increasing prevalence of chronic pain conditions is expected to propel the growth of the morphine drugs market going forward. Chronic pain is a complex condition characterized by persistent discomfort that lasts for an extended period, which serves as a warning signal of injury or illness. Chronic pain has grown into a serious health concern globally due to several interrelated variables, such as aging populations, rising obesity rates, sedentary lifestyles, stress and mental health difficulties, and environmental factors. Morphine is necessary to control chronic pain as it is highly effective in relieving pain and may be customized to meet the specific demands of each patient. It enhances life quality and enables those who suffer from chronic pain to achieve more without experiencing excruciating pain all the time. For instance, in May 2021, according to the Government of Canada, a Canada-based federal administration, up to 8.3 million Canadians may experience chronic pain by 2025, and it is expected to reach up to 9.0 million by 2030. Therefore, the increasing prevalence of chronic pain conditions is driving the growth of the morphine drug industry.

Key Players In The Global Morphine Drugs Market

Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA

Global Morphine Drugs Market Trends and Insights

Major companies operating in the morphine drug market are focusing on developing advanced delivery systems, such as prefilled syringe formats, to boost efficiency, enhance safety, and reduce medication errors and preparation time. Prefilled syringes refer to sterile, single-dose delivery systems that are pre-filled with a specific medication, eliminating the need for manual drawing from a vial before administration. For instance, in April 2024, Hikma Pharmaceuticals PLC, a UK-based multinational pharmaceutical company, launched Morphine Sulfate Injection USP in a prefilled syringe in the U.S. This offering provides a ready-to-use, sterile presentation of the opioid analgesic, which enhances convenience for healthcare providers in acute care settings. The prefilled syringe is designed to help reduce dosing errors and improve workflow efficiency by minimizing preparation steps.

What Are Latest Mergers And Acquisitions In The Morphine Drugs Market?

In January 2024, CDMO Bora Pharmaceuticals Inc., a Taiwan-based pharmaceutical company, acquired Upsher-Smith Laboratories Inc. for $210 million. Through this acquisition, Bora aims to strengthen its position in the generics market, potentially expanding its product range, improving manufacturing capacity, fostering innovation, and exploring entry into new geographic markets. Upsher-Smith Laboratories Inc. is a US-based pharmaceutical company that manufactures morphine drugs.

Regional Insights

North America was the largest region in the morphine drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Morphine Drugs Market?

The morphine drugs market consists of sales of morphine sulfate, Roxanol oral solution, Kadian capsules, morphine injections, and Avinza capsules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Morphine Drugs Market Report 2026?

The morphine drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the morphine drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.